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Dear Sir,
A consistent amount of experimental 
data suggest the hypothesis that neutrophils 
participate in the pathophysiology of the he­
molytic-uremic syndrome (HUS) [1-3], As a 
matter of fact, an increased adherence of 
neutrophils to the endothelium has been 
demonstrated in HUS [1], together with an 
augmented release of neutrophil-derived 
proteinases. such as clastasc [3],
Antincutrophil cytoplasmic antibodies 
(ANCA) have been demonstrated to be able 
to induce neutrophil degranulation and pro­
duce oxygen radicals in vitro [4], when 
primed by cytokines, such as TNF-a or IL-1. 
or products from infectious agents, as occurs 
in Wegener’s granulomatosis, following a re­
spiratory tract infection [5], Therefore, Rol- 
lino et al. [6] who recently found the serum 
of one HUS patient (out of 4 tested) positive 
for both antiproteinase 3 (PR3-Abs, or C- 
ANCA) and antimycloperoxidase (MPO- 
Abs, or P-ANCA) antibodies, postulated the 
participation of ANCA, together with anti- 
elastasc antibodies, in the pathophysiology 
of HUS, at least in certain patients. Throm­
botic thrombocytopenic purpura (TTP) is a 
rare hematological disorder, which shares a 
lot of striking similarities with HUS. espe­
cially in adults. Extremely debated is still the 
hypothesis that these two diseases arc simply 
the qualitative different expression of a 
unique physiopathological substrate. Even if 
the microthrombi found in the microcircula­
tion of TTP patients usually lacks polymor­
phonuclear cells, consisting only of platelets
and hyaline, PAS-positive substances, we de­
cided to look for the eventual presence of 
ANCA in sera of acute-phase TTP patients. 
It is in fact theoretically possible that neutro­
phils could initiate, via ANCA-induced dc- 
granulation and free radicals production, the 
endothelial damage that ultimately leads to 
the clinical pattern of acute TTP. without 
leaving behind them clear evidence of their 
involvement.
Twenty-nine adult TTP patients were 
studied during the acute phase of the disease; 
TTP had been diagnosed in the presence of 
the following signs: thrombocytopenia 
(< 100 x 10‘VI), microangiopathic anemia 
(demonstrated by the presence of schizo­
cytes in peripheral blood smears), no dissem­
inated intravascular coagulation, no anti- 
erythroevte and antiplatelet antibodies, high 
LDH levels, and signs of neurological in­
volvement. The diagnosis of HUS was ruled 
out since all our patients showed only slight 
signs of renal involvement: as a matter of 
fact, none of our patients showed serum 
BUN and creatinine exceeding 60 and 
1.3 mg%, respectively, the only signs of kid­
ney compromise being the presence of mi­
crohematuria (in all patients) and cylindru- 
ria (in 6 of them) at urinalysis. Furthermore, 
in 4 of these patients, stool examination led 
us to exclude the presence of enterotoxins 
producing Ercherichia coli strains.
ANCA were searched for by an indirect 
immunofluorescence technique according to 
the method of Wiik (7). Granulocyte isola­
tion was performed from heparinized whole 
blood sample by 6% dextran sedimentation 
and a Ficoll-Hypaque density gradient, as 
described elsewhere [8]. Isolated granulo­
cytes were repeatedly washed in PBS. pH 
7.4. containing 1% human serum albumin, 
cytocentriluged on defatted glass slides, and 
then fixed in absolute ethanol for 5 min at 
4°C. Granulocyte substrate was incubated 
with patient serum diluted 1:20 in PBS for 
20 min in a humidity chamber, then washed 
three times in PBS and incubated with 
FITC-conjugatcd rabbit Ig specific for hu­
man IgG (Dakopatts. Glostrup. Denmark) 
diluted 1:50 in PBS. After three additional 
washings, the slides were covered by a 2:1 
glycerol-PBS mixture and a cover glass and 
read in an epi-illumination Leitz micro­
scope.
Different to the observation of Rollino et 
al. [6] in 1 HUS patient, a completely nega­
tive ANCA assay was found in all TTP 
patients tested.
ANCA can be found in the circulation of 
several patients affected by systemic necro­
tizing vasculitis, such as Wegener’s granulo­
matosis, microscopic polyarteritis nodosa, 
leukocytoclastic angiitis, necrotizing and 
crescentic glomerulonephritis, Churg- 
Strauss syndrome, classic polyarteritis nodo­
sa and Tolosa-Hunt syndrome, and have 
also been recently proposed as possible ini­
tiators of the vascular damage which can be 
found in HUS [6]. The absence of ANCA in 
the sera of our 29 acute-phase TTP patients,
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seems to exclude the involvement of these 
autoantibodies in the pathogenesis of TTP. 
Moreover, even in HUS, we are far from 
having a clear demonstration of ANCA’s 
participation in the etiopathogenesis of this 
disease: the concomitant C-ANCA and P- 
ANCA positivity reported by Rollino et al. 
[6] in 1 patient could be a casual association, 
since patients with vasculitis virtually never 
have both types of antibodies [9. 10] as 
would be expected if the autoantibody for­
mation was a secondary phenomenon [10]. 
However, the role of other autoantibodies in 
the etiopathogenesis of TTP deserves further 
investigation; as a matter of fact, the com­
plex relationship existing between anticar- 
diolipin (aCL-Abs). TTP and systemic lupus 
erythematosus (SLE), which often shares a 
number of similarities with TTP and is 
sometimes associated with it. is currently 
under scrutiny by our group.
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